ALL Case Study

1238 Words 5 Pages
Register to read the introduction… Chemotherapeutic agents are chosen because of their ability to interfere with oncologic cell division. The treatment of ALL involves 3 phases: remission induction, consolidation, and maintenance therapy. Pediatric patients with ALL are often given 8 or more months of intensive chemotherapy. This is often followed by maintenance therapy of two or more years (Gedaly-Duff et al., 2006). Most treatment protocols use systemic chemotherapy with or without radiotherapy (McCance & Huether, 2010). According to a study conducted by McDonald & Mc Carthy (2005), success of chemotherapy and remission depends on “aggressive induction chemotherapy followed by delayed intensification and maintenance therapy, p. …show more content…
Ghazi, A.A., Attarian, H., Attarian, S., Abasahl, A., Daryani, E., Farasat, E., …Kovacs, K.
(2010). Hypercalcemia and huge splenomegaly presenting in an elderly patient with B- cell non-Hodgkins Lymphoma: a case report. Journal of medical case reports, (4)330. from
Lee H.J, Thompson JE, Wang ES, Wetzler M. (2011) Philadelphia Chromosome-Positive

cute Lymphoblastic Leukemia Current Treatment and Future Perspectives. Cancer.

Marchesi F, Girardi K, Avvisati G. (2011) Pathogenetic, Clinical, and Prognostic Features

of Adult t(4;11)(q21;q23)/MLL-AF4Positive B-Cell Acute Lymphoblastic Leukemia.

AdvHematol. 2011;2011:62162.
McCance, K.L. & Huether, S.E. (Eds). 2010. Pathophysiology: The biological basis of disease in adults and children (6th ed.) Mosby: St. Louis
McDonald, L.R. & McCarthy, C.H. (2005). Nursing Considerations for Clofarabine. Clinical Journal of Oncology Nursing, (10)6.
Nazki F.H, Masood A, BandayMA,Bhat A, GanaiBA. (2012)Thymidylate synthase enhancer

region polymorphism not related to susceptibility to acute lymphoblastic leukemia

in the Kashmir population.Genet. Mol. Res. 11 (2):

Related Documents